Agilent Technologies (NYSE:A) Releases Q4 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its fourth quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 1.710-1.740 for the period, compared to the consensus earnings per share estimate of 1.710. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion. Agilent Technologies also updated its FY 2026 guidance to 6.180-6.210 EPS.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. TD Cowen lifted their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Barclays raised their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Morgan Stanley lifted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Finally, Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Stock Up 0.3%

NYSE A traded up $0.39 during mid-day trading on Wednesday, hitting $155.16. The company’s stock had a trading volume of 3,131,622 shares, compared to its average volume of 2,234,282. The firm has a market capitalization of $43.82 billion, a price-to-earnings ratio of 31.16, a PEG ratio of 2.71 and a beta of 1.25. The company’s 50 day simple moving average is $138.55 and its 200 day simple moving average is $126.47. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $160.51.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts anticipate that Agilent Technologies will post 6.05 earnings per share for the current year.

Hedge Funds Weigh In On Agilent Technologies

A number of hedge funds have recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies during the second quarter valued at approximately $273,000. Brighton Jones LLC lifted its holdings in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. IFC & Insurance Marketing Inc. purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at approximately $155,000. SmartHarvest Portfolios LLC bought a new position in shares of Agilent Technologies in the fourth quarter worth $203,000. Finally, Zions Bancorporation National Association UT boosted its stake in Agilent Technologies by 17.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 990 shares of the medical research company’s stock worth $135,000 after purchasing an additional 145 shares during the period.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.